Menactra availablity
November 14, 2011
SANOFI Pasteur’s Menactra,
Meningococcal (Groups A, C, Y, W-
135) Polysaccharide Diphtheria
Toxoid Conjugate vaccine is now
available in Australia.
Indicated for the prevention of
invasive meningococcal disease
caused by N. meningitidis
serogroups A, C, Y and W-135 the
vaccine is the only quadrivalent
conjugate meningococcal vaccine
indicated for use in Australia for
children aged from 2 – 11 years,
and is suitable for use in persons
aged 2-55 years.
“The number of Australians
travelling to high risk areas such as
Asia, Africa and the Middle East is
on the increase, so prior to
departure, consideration of
meningococcal vaccination should
be part of travel plans,” said Sydney
University, Professor Robert Booy.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Nov 11To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Nov 11
